Publication | Open Access
STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma
122
Citations
26
References
2010
Year
Our results suggest that using WP1066 to inhibit the STAT3 signalling pathway could be a novel therapeutic strategy against RCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1